Clinical Trials Browser

Active not recruiting × Lymphoma × polatuzumab vedotin × Clear all

NCT05410418 2025-12-15

Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma

Phase 2 Active not recruiting

Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell